• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

5-Fluorouracil Combo Promising

Article

Chicago - The combination of oxaliplatin (Eloxatin) and a continuous infusion of 5-fluorouracil (5-FU) appears to offer a promising chemotherapeutic alternative to the presently administered cisplatin or carboplatin-based approach for the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck, Marc Debled, M.D., said at the American Society of Clinical Oncology meeting.

Related Videos
Related Content
Journal Digest: December 8

Journal Digest: December 8

Article
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath

The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath

Podcast
Celebrating 2023’s Achievements in Dermatology

Celebrating 2023’s Achievements in Dermatology

Article
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Podcast
High Levels of Cholesterol, Low-Density Lipoprotein Cholesterol, Among Genetic Risk Factors for Psoriasis

High Levels of Cholesterol, Low-Density Lipoprotein Cholesterol, Among Genetic Risk Factors for Psoriasis

Article
Dermavant Shares Positive Phase 4 Data for Tapinarof 1% in Adults With Plaque Psoriasis of the Head and Neck

Dermavant Shares Positive Phase 4 Data for Tapinarof 1% in Adults With Plaque Psoriasis of the Head and Neck

Article
© 2023 MJH Life Sciences

All rights reserved.